Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)
India · Delayed Price · Currency is INR 115.69
-6.08 (-4.99%)
At close: Apr 29, 2026
NSE:GAUDIUMIVF Revenue
Gaudium IVF and Women Health had revenue of 245.07M INR in the quarter ending December 31, 2025, with 54.66% growth. This brings the company's revenue in the last twelve months to 1.01B. In the fiscal year ending March 31, 2025, Gaudium IVF and Women Health had annual revenue of 707.24M with 47.68% growth.
Revenue (ttm)
1.01B
Revenue Growth
+47.68%
P/S Ratio
8.78
Revenue / Employee
8.63M
Employees
117
Market Cap
8.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 707.24M | 228.34M | 47.68% |
| Mar 31, 2024 | 478.90M | 36.35M | 8.21% |
| Mar 31, 2023 | 442.55M | 77.36M | 21.18% |
| Mar 31, 2022 | 365.20M | 303.45M | 491.39% |
| Mar 31, 2021 | 61.75M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bluspring Enterprises | 32.18B |
| Century Enka | 16.66B |
| Sathlokhar Synergys E&C Global | 6.58B |
| New Delhi Television | 5.07B |
| Prostarm Info Systems | 3.63B |
| Sejal Glass | 3.50B |
| Jaro Institute of Technology Management and Research | 2.75B |
| Eimco Elecon (India) | 2.31B |